Disc Medicine Shares Jump 21% On Upcoming Data Presentation

(RTTNews) - Disc Medicine, Inc. (IRON) shares surged 21.12 percent to $90.07 gaining $15.71 on Friday after the company announced plans to present new clinical data at the 2025 American Society of Nephrology Kidney Week in Houston this November.

The stock traded between $83.88 and $95.95 during the session, compared with a previous close of $74.36 on the Nasdaq. Volume stood at 1.68 million shares, far above the average of 354,075. Over the past 52 weeks, shares have traded between $30.82 and $95.95.

The presentation will include results from its Phase 1b study of DISC-0974 in patients with non-dialysis-dependent chronic kidney disease and anemia, covering safety, tolerability, and pharmacodynamic activity.